Treatment of gum recession using growth factor therapy

Efficacy of recombinant human fibroblast growth factor impregnated scaffold in the management of isolated maxillary gingival recession - A randomised controlled clinical trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091569

Enrollment

Registered

2025-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K055- Other periodontal diseases

Interventions

Intervention1: FGF group: Recombinant human fibroblast growth factor impregnated collagen scaffold will be used as soft tissue substitute for treatment of isolated gingival recession in maxilla in com

Eligibility

Inclusion criteria

Inclusion criteria: RT1 type recession Maxillary gingival recession Isolated gingival recession Thin soft tissue phenotype FMBS less than 20 FMPS less than 20

Exclusion criteria

Exclusion criteria: mokers Tobacco users Pregnancy Lactating mothers Not available for 24 months follow up Unwilling for periodic recall every 3 months

Design outcomes

Primary

Measure	Time frame
Changes in recession height Changes in recession width Mean root coverage Complete root coverage Visual analog scale Patient reported outcome measuresTimepoint: Baseline, 3 Months, 6 Months, 9 Months, 12 Months	—

Secondary

Measure	Time frame
Patient satisfaction Incidence of complicationsTimepoint: 0,3,6,9,12 months	—

Countries

India

Contacts

Public ContactDrSaravanan SP

Army Dental Centre Research Referral Delhi

saravananacademics@gmail.com9637110906

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026